In H pylori infection, vonoprazan plus high-dose amoxicillin was noninferior to B-quadruple therapy for eradication.
Ann Intern Med
; 176(5): JC54, 2023 05.
Article
em En
| MEDLINE
| ID: mdl-37126819
ABSTRACT
SOURCE CITATION Qian HS, Li WJ, Dang YN, et al. Ten-day vonoprazan-amoxicillin dual therapy as a first-line treatment of Helicobacter pylori infection compared with bismuth-containing quadruple therapy. Am J Gastroenterol. 2023;118627-634. 36729890.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Helicobacter pylori
/
Infecções por Helicobacter
Limite:
Humans
Idioma:
En
Revista:
Ann Intern Med
Ano de publicação:
2023
Tipo de documento:
Article